A cardiac surgery insulin protocol uses insulin infusions and injections to keep glucose around 110–180 mg/dL before, during, and after surgery.
Cardiac surgery puts heavy stress on the body. Stress hormones push blood sugar up even in people who never had diabetes. In people who live with diabetes, the swing can be steep and can linger for days. Without a clear perioperative insulin plan, glucose can drift high or low, and both ends of that range raise risk for infection, delayed healing, and longer stays in the intensive care unit.
To manage that risk, many centers rely on a cardiac surgery insulin protocol that standardizes how staff check glucose, start intravenous insulin, transition to subcutaneous doses, and treat low readings. The goal is not perfect numbers. The goal is steady, safe control that fits current hospital standards while staying practical for busy operating room and ICU teams.
This article walks through why glucose management matters so much around heart surgery, common target ranges, and how the protocol usually flows from the night before surgery through discharge. It is written to help patients, families, and clinicians speak the same language when they review local orders and policies. It cannot replace local policy or direct advice from the treating team, but it can make those conversations clearer.
What A Cardiac Surgery Insulin Protocol Tries To Achieve
Any structured insulin plan around heart surgery balances three objectives. First, it limits sustained hyperglycemia that can feed infection, worsen fluid shifts, and strain the heart. Second, it protects the patient from hypoglycemia, which can trigger arrhythmias, confusion, and seizures. Third, it keeps the process simple enough that every team member can follow it without delay or guesswork.
Modern hospital guidance no longer pushes very tight glucose control. Large trials saw more hypoglycemia and no survival benefit when teams chased near normal readings in unstable patients. Groups such as the American Diabetes Association recommend starting treatment when glucose rises above 180 mg/dL in the hospital and aiming for roughly 140–180 mg/dL for most critically ill adults, including many after heart surgery.
The Society of Thoracic Surgeons has long supported keeping intraoperative glucose below about 180 mg/dL and fasting or premeal readings closer to 110 mg/dL when safe. These ranges reflect the idea that modest hyperglycemia is less dangerous than frequent lows during and after complex bypass cases. A good protocol writes those targets into clear tables and order sets so that bedside nurses do not have to calculate ranges on the fly.
Insulin Protocols In Cardiac Surgery By Phase Of Care
Every hospital builds its own orders, yet most cardiac insulin protocols share the same phases. Glucose targets and insulin choices shift as the patient moves from preoperative holding through the operating room into the ICU and then the ward. The table below summarizes common patterns that line up with major cardiac and diabetes society guidance.
| Phase | Typical Glucose Target (mg/dL) | Common Insulin Strategy |
|---|---|---|
| Night Before Surgery | 100–180 | Reduce long acting dose; hold most rapid acting insulin after midnight |
| Preoperative Holding | 100–180 | Check point of care glucose; correction scale subcutaneous insulin or start IV insulin if >180 |
| Intraoperative On Bypass | 120–180 | Continuous IV insulin infusion with hourly glucose checks |
| Immediate Post Bypass | 120–180 | Continue IV infusion; adjust based on rate of change and vasopressor use |
| First 24 Hours In ICU | 140–180 | IV infusion with hourly to every two hour checks until stable, then wean frequency |
| Transition To Ward | 100–180 | Switch to basal bolus injections; stop IV infusion one to two hours after first basal dose |
| Pre Discharge | 80–180 | Adjust home regimen; organize teaching and follow up for diabetes care |
Targets in this range reflect evidence that keeping readings under about 180 mg/dL reduces infection and organ stress without driving up severe hypoglycemia. The American Diabetes Association Standards of Care describe 140–180 mg/dL as a common goal for many critically ill patients in hospital settings, including those in a cardiac ICU. The Society of Thoracic Surgeons blood glucose guideline for adult cardiac surgery follows a similar course.
Local teams still adjust these numbers. Some centers pick a narrower band such as 110–150 mg/dL, especially for younger patients with fewer comorbidities. Others stay near 140–180 mg/dL for almost everyone. What matters most is that the target range and insulin orders match, and that nurses know exactly when to call an anesthesiologist, intensivist, or endocrinology service.
Stepwise Insulin Management On The Day Of Surgery
The day of surgery starts with a fasting glucose check. For patients with type 1 diabetes, the protocol usually keeps a reduced basal dose on board to prevent ketoacidosis. For those with type 2 diabetes, long acting insulin is often given at 60–80 percent of the usual dose, while short acting insulin for meals is held. Oral agents such as SGLT2 inhibitors and some GLP 1 receptor agonists are generally stopped days before major surgery because of nausea or ketoacidosis risk.
In preoperative holding, the nurse or anesthesiology team checks bedside glucose and follows a correction scale. Mild elevations might call for a small subcutaneous correction. Readings above a threshold, often 180 mg/dL, usually trigger an intravenous insulin infusion. Once the patient reaches the operating room, that infusion continues with hourly glucose checks and clear adjustment rules based on current value and rate of change.
A well written cardiac surgery insulin protocol explains exactly how to titrate that infusion. Many use weight based tables where nurses move up or down rows as glucose climbs or falls. The adjustment table may also include guidance for patients who receive high dose steroids or vasopressors, both of which can push glucose higher. Clear written rules and nurse driven titration keep the process timely in a busy operating room.
Postoperative Insulin Protocol In The Icu And Ward
After surgery, patients usually stay on a continuous insulin infusion in the ICU until they are hemodynamically stable and able to take food or tube feeds. Hourly glucose checks continue until several readings land in the goal range. Teams then stretch the interval to every two hours or every four hours while the drip rate holds steady. Bedside staff also watch trends, since a steady drop toward the lower edge of the target band may signal that the infusion rate should fall.
Transition from intravenous insulin to subcutaneous doses is a delicate moment. One common approach is to calculate the total insulin used in the previous six to eight hours and use that to estimate a 24 hour requirement. Part of that goes into a long acting basal injection, with the rest split into rapid acting doses matched to meals or feeding schedules. The drip continues for one to two hours after the basal shot to prevent a gap in coverage.
On the step down unit or ward, many patients shift to a standard basal bolus plan with a correction scale. Glucose checks line up with meals and bedtime. Targets often sit in the 100–180 mg/dL range for stable patients who are eating. If appetite is poor or tube feeds are intermittent, the protocol may recommend more frequent checks and smaller rapid acting doses to avoid lows.
Special Situations And Patient Groups
Not every patient fits the same insulin plan. People with type 1 diabetes, those with long standing type 2 diabetes on high dose insulin, and those with kidney or liver disease need adjustments. So do older, frail adults and people with a history of severe hypoglycemia. A safe cardiac insulin protocol spells out how to adapt the standard course for these groups.
| Patient Group | Common Adjustment | Main Safety Reason |
|---|---|---|
| Type 1 Diabetes | Never stop basal insulin; favor IV infusion during fasting | Prevents ketoacidosis and wide swings |
| Type 2 On High Dose Insulin | Start IV infusion earlier; base basal dose on recent drip needs | Reduces severe hyperglycemia after bypass |
| Type 2 On Oral Agents Only | Hold orals; start correction scale, then add basal bolus if readings stay high | Lowers risk from metformin, sulfonylureas, and SGLT2 inhibitors |
| Chronic Kidney Disease | Use lower starting doses; extend intervals between titration steps | Decreased insulin clearance raises risk of prolonged hypoglycemia |
| Liver Disease | Avoid aggressive boluses; rely on careful infusion titration | Impaired gluconeogenesis makes lows harder to correct |
| Older Or Frail Adults | Relax lower glucose bound to 150 mg/dL in ICU and 110 mg/dL on ward | Less reserve for hypoglycemia and falls |
| High Dose Steroids | Expect higher drip rates and extra prandial doses | Steroid induced insulin resistance raises glucose quickly |
When a hospital writes this level of detail into its orders, bedside staff can adapt without long delays while still staying within safe bounds. Many teams review recent evidence and national guidance each year and refresh their insulin protocol. Groups such as the Society of Thoracic Surgeons and the American Diabetes Association post updated cardiac surgery and hospital glucose targets online, along with tools that help translate those targets into bedside orders.
How Teams Build And Maintain A Safe Insulin Protocol
An effective cardiac insulin protocol starts with a small working group. Cardiac surgeons, anesthesiologists, intensivists, endocrinologists, pharmacists, and bedside nurses sit together to review current outcomes and glucose data. They define a target range for each phase, agree on a simple titration table, and decide which service owns protocol updates. Electronic order sets, bedside posters, and pocket cards then turn that plan into daily practice.
Once the protocol goes live, steady feedback keeps it safe. Units track episodes of severe hypoglycemia, deep sternal wound infection, and length of stay. They also watch how often staff deviate from the written plan and ask why. Frequent off protocol moves may signal that the titration table is too complex or that the targets do not match current patient needs. Modest quarterly adjustments are easier and safer than rare sweeping changes.
From a patient and family perspective, this insulin protocol is one more layer of protection. It helps the team respond quickly to high readings, avoid dangerous lows, and send people home on a regimen that matches their new level of activity. Clear written orders, regular staff education, and alignment with trusted references such as the American Diabetes Association Standards of Care and the Society of Thoracic Surgeons guideline all point in the same direction: steady glucose, safer recovery, and fewer surprises after heart surgery.